This condition can lead to sudden vision loss.

Building on these findings, a new preprint study from Denmark and Norway has reaffirmed the association.

Despite this, the absolute risk remains low.

A close up photo of a light blue eye, slightly blurred for style.

Ion Fet/Unsplash

Only 32 cases of NAION were reported in the study, which included data from over 60,000 people.

Semaglutide is widely used to treat key in 2 diabetes and obesity.

What Is NAION?

NAION is a rare eye condition that mainly affects people over the age of 50.

Is the Risk Being Investigated?

Reutersreported that the European Union drug agency plans to investigate potential NAION risks related to semaglutide.

Novo Nordisk, the company that makes Ozempic, toldReutersthat patient safety is their top priority.

Should People Stop Ozempic If Theyre Worried About NAION?

This isn’t the same as NAION, which causes permanent vision loss.

Semaglutide actually is known for itsanti-inflammatoryproperties, said Srivastava.

I have lots of patients who have improvement of their neuropathic or neuropathy symptoms on the semaglutide.

However, its important to monitor any changes in vision and discuss concerns with your healthcare provider.

Your provider can help you weigh the risks and benefits based on your individual health needs.

2024;142(8):732-732. doi:10.1001/jamaophthalmol.2024.2296

National Kidney Foundation.SGLT2 inhibitors.

American Academy of Ophthalmology.NAION: diagnosis and management.

Puddu A, Maggi D.Anti-inflammatory effects of GLP-1R activation in the retina.Int J Mol Sci.

2022;23(20):12428. doi:10.3390/ijms232012428